Statin therapy increases the risk of new-onset diabetes in elderly women
by 33%, and the higher the dose, the greater the risk,
new research shows.
The title of the
paper is:New-Onset Diabetes After Statin Exposure in Elderly Women: The Australian Longitudinal Study on Women’s Health
and its implications are rather significant.
"GPs and their elderly female patients should be aware of the risks,"
Dr Jones added in a University of Queensland statement, noting that
those elderly women taking statins "should be carefully and regularly
monitored for increased blood glucose to ensure early detection and
management of diabetes."
And, he and his colleagues suggest, it may be the case
that statins could be stopped altogether in some elderly women.
"What's most concerning was that we found a 'dose effect,' where the
risk of diabetes increased as the dosage of statins increased, [and]
over the 10 years of the study, most of the women progressed to higher
doses of statins," Dr Jones observed.
He
and his colleagues therefore recommend that ongoing risk assessment is
"critical" to ensure optimal health outcomes and quality of life in
older women.